Michael A. Gellar

570 total citations
14 papers, 483 citations indexed

About

Michael A. Gellar is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A. Gellar has authored 14 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Internal Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A. Gellar's work include Venous Thromboembolism Diagnosis and Management (12 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Acute Myocardial Infarction Research (3 papers). Michael A. Gellar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Acute Myocardial Infarction Research (3 papers). Michael A. Gellar collaborates with scholars based in United States. Michael A. Gellar's co-authors include John A. Watts, Jeffrey A. Kline, John Zagorski, Jacob P. Debelak, Nina Sanapareddy, Michael S. Runyon, Jeffrey A. Kline, Sun‐Il Hwang and Michael R. Marchick and has published in prestigious journals such as The Journal of Immunology, Critical Care Medicine and Journal of Molecular and Cellular Cardiology.

In The Last Decade

Michael A. Gellar

14 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Gellar United States	12	243	231	208	72	72	14	483
Marie‐Laure Ozoux France	10	301 1.2×	333 1.4×	63 0.3×	82 1.1×	61 0.8×	18	581
David Gurney United Kingdom	9	119 0.5×	193 0.8×	43 0.2×	50 0.7×	147 2.0×	12	436
Andrew Blann United Kingdom	8	64 0.3×	143 0.6×	43 0.2×	89 1.2×	58 0.8×	8	398
Trevor A. Bayston United Kingdom	10	279 1.1×	281 1.2×	162 0.8×	94 1.3×	507 7.0×	12	835
A D Blann United Kingdom	6	47 0.2×	121 0.5×	73 0.4×	42 0.6×	69 1.0×	7	333
Herm Jan M. Brinkman Netherlands	12	174 0.7×	225 1.0×	34 0.2×	59 0.8×	165 2.3×	18	471
Sanne Bøjet Larsen Denmark	13	47 0.2×	174 0.8×	61 0.3×	58 0.8×	49 0.7×	24	382
P A Merlini Italy	4	160 0.7×	388 1.7×	65 0.3×	33 0.5×	107 1.5×	6	520
Felix Gerhardt Germany	12	47 0.2×	231 1.0×	296 1.4×	40 0.6×	40 0.6×	28	416
Zihui Xiao China	10	217 0.9×	406 1.8×	35 0.2×	66 0.9×	106 1.5×	13	616

Countries citing papers authored by Michael A. Gellar

Since Specialization

Citations

This map shows the geographic impact of Michael A. Gellar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Gellar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Gellar more than expected).

Fields of papers citing papers by Michael A. Gellar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Gellar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Gellar. The network helps show where Michael A. Gellar may publish in the future.

Co-authorship network of co-authors of Michael A. Gellar

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Gellar. A scholar is included among the top collaborators of Michael A. Gellar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Gellar. Michael A. Gellar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Watts, John A., et al.. (2012). A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism. Pulmonary Pharmacology & Therapeutics. 26(2). 205–211. 6 indexed citations

Watts, John A., et al.. (2011). Proteomics of microparticles after experimental pulmonary embolism. Thrombosis Research. 130(1). 122–128. 28 indexed citations

Watts, John A., et al.. (2011). Pulmonary vascular reserve during experimental pulmonary embolism: Effects of a soluble guanylate cyclase stimulator, BAY 41-8543*. Critical Care Medicine. 39(12). 2700–2704. 22 indexed citations

Watts, John A., et al.. (2011). Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism. Pulmonary Pharmacology & Therapeutics. 25(1). 48–54. 18 indexed citations

Watts, John A., et al.. (2011). Effects of angiotensin (1-7) upon right ventricular function in experimental rat pulmonary embolism.. PubMed. 26(10). 1287–94. 4 indexed citations

Watts, John A., Michael R. Marchick, Michael A. Gellar, & Jeffrey A. Kline. (2011). Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism. Pulmonary Pharmacology & Therapeutics. 24(4). 407–413. 16 indexed citations

Runyon, Michael S., Michael A. Gellar, Nina Sanapareddy, Jeffrey A. Kline, & John A. Watts. (2010). Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats. Thrombosis Journal. 8(1). 3–3. 29 indexed citations

Watts, John A., et al.. (2009). Proinflammatory Events in Right Ventricular Damage During Pulmonary Embolism: Effects of Treatment With Ketorolac in Rats. Journal of Cardiovascular Pharmacology. 54(3). 246–252. 24 indexed citations

Zagorski, John, et al.. (2009). Transcriptional changes in right ventricular tissues are enriched in the outflow tract compared with the apex during chronic pulmonary embolism in rats. Physiological Genomics. 39(1). 61–71. 17 indexed citations

10.

Watts, John A., et al.. (2008). Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. International Journal of Experimental Pathology. 89(5). 389–399. 61 indexed citations

11.

Zagorski, John, Nina Sanapareddy, Michael A. Gellar, Jeffrey A. Kline, & John A. Watts. (2008). Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats. Physiological Genomics. 34(1). 101–111. 33 indexed citations

12.

Zagorski, John, et al.. (2007). Inhibition of CINC-1 Decreases Right Ventricular Damage Caused by Experimental Pulmonary Embolism in Rats. The Journal of Immunology. 179(11). 7820–7826. 48 indexed citations

13.

Watts, John A., et al.. (2006). Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. Journal of Molecular and Cellular Cardiology. 41(2). 296–307. 105 indexed citations

14.

Zagorski, John, Jacob P. Debelak, Michael A. Gellar, John A. Watts, & Jeffrey A. Kline. (2003). Chemokines Accumulate in the Lungs of Rats with Severe Pulmonary Embolism Induced by Polystyrene Microspheres. The Journal of Immunology. 171(10). 5529–5536. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact